Neurodawn Pharmaceutical Co., Ltd.
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Neurodawn Pharmaceutical Co., Ltd. as a sponsor: 7 trials, 0 as lead sponsor and 7 as collaborator.
Phase and status
| Phase | Not yet recruiting | Completed | Unknown status | All statuses |
|---|---|---|---|---|
| Phase 2 | 0 | 1 | 3 | 4 |
| Phase 3 | 1 | 2 | 0 | 3 |
| All phases | 1 | 3 | 3 | 7 |
Start year
| Start year | Trials |
|---|---|
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 5 |
Main conditions
Main countries
- China
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Neurodawn Pharmaceutical Co., Ltd.
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-neurodawn-pharmaceutical-co-ltd- Content hash
37180a1d1867d920eebeee0a65c55d4d83be46056833768820f22b7233e3e1b7